Understanding MMD Lab Testing: Clinical Insights, Clearance Support, and Current Projects
SARS-CoV-2 Spike (S1) and Nucleocaspid (N1) protein testing has become a point of interest for people who remain unwell after COVID-19 infection, vaccination, or a combination of both. The question I hear most often in clinical practice is simple: “Is there still spike protein in my body, and is it contributing to how I feel?”
At BeNourished we use MMD Labs to measure N1 and S1 levels in Exosomes and Immune cells and this is one tool that may help answer part of that question. It does not diagnose every cause of fatigue, inflammation, immune disruption, clotting changes, brain fog, pain, or post-viral illness. It also should not be used in isolation. But, when interpreted carefully, it can add useful information to the wider clinical picture.
Here I explain what this testing may show, what the results can and cannot tell us, what I am seeing in clinical practice, and some of the interventions currently being used to support clearance and recovery.
This content is for educational purposes only. It is not medical advice, and testing or treatment decisions should be made with a suitably qualified practitioner.
What spike and nucleocapsid protein testing is trying to measure
The spike protein (S1) is the structure SARS-CoV-2 uses to bind to human cells. It is also the protein targeted by several COVID-19 vaccines. In most people, immune activity related to spike exposure settles with time. However some clinicians and researchers are exploring whether spike protein, spike fragments, or related immune responses may persist and contribute to ongoing symptoms. On the other hand the nucleocapsid protein (N1) is an internal RNA-packaging protein, which is abundant during infection and has central roles in packaging viral RNA and interacting with the host immune responses.
MMD Lab tests for S1 and N1 in plasma, exosomes and PBMC's (immune cells). S1 can derive from SARS-CoV-2 infection, and may also be relevant to prior exposure to spike-based vaccination or vaccine-derived mRNA, depending on the assay, timing, and biology. It is therefore not infection-specific on its own. N1 detection is generally viewed as more supportive of prior viral infection/exposure than spike alone, because currently authorised spike-based vaccines do not encode or contain nucleocapsid protein.
A positive result may suggest:
Whether spike or nucleocapsid related material is detectable
Whether levels appear low, moderate, or higher, depending on the lab’s reporting method
Whether repeated testing shows a pattern over time
Whether there may be a reason to look more closely at immune activation, inflammation, clotting markers, or viral persistence
A single result rarely gives the whole answer. A positive finding does not automatically prove causation. A negative result does not rule out post-COVID or post-vaccine illness. Biology is rarely that tidy.
What the results can inform on
The real value of testing comes from putting it in context. I find the most useful interpretation comes when results are viewed alongside symptoms, history, and other investigations.
Symptom patterns
Some people with detectable S1 and N1 related markers report symptoms such as:
Fatigue that does not improve with rest
Brain fog or reduced concentration
Post-exertional symptom flares
Muscle or joint pain
Headaches
Palpitations or dysautonomia like symptoms
Sleep disturbance
New sensitivities to foods, alcohol, heat, or exertion
Ongoing inflammatory symptoms after infection or vaccination
Flu like symptoms
These symptoms are not specific to spike or nucleocapsid protein. They can overlap with long COVID, mast cell activation, autoimmune conditions, thyroid disease, nutritional deficiencies, mould exposure, chronic infections, and other inflammatory states.
That is why testing should guide thinking, not replace it.
Immune and inflammatory burden
If spike or nucleocapsid related material is detected, it may prompt a clinician to ask broader questions:
Is the immune system still activated?
Are inflammatory markers raised?
Are clotting or vascular markers abnormal?
Is there evidence of reactivated viruses, such as Epstein-Barr virus?
Is gut barrier function affected?
Is detoxification capacity impaired?
Is the person tolerating exertion, fasting, supplements, and medication?
The aim is not to chase one marker. The aim is to understand why the person has not returned to baseline.
Progress over time
Repeat testing can sometimes be more useful than a one-off test. If levels reduce alongside symptom improvement, that may support the chosen approach. If symptoms improve but the marker remains present, the result may be less clinically important for that person. If symptoms remain severe despite changes in the marker, other drivers need attention.
This is where careful clinical judgement matters.
What I am finding in clinical practice
In clinical practice, the people asking about testing are often not mildly unwell. Many have already seen several practitioners. They may have normal routine blood tests, yet still feel far from well.
The patterns I see most often include three broad groups.
People with post-infectious illness
Some people became unwell after confirmed or suspected COVID-19 infection. They may describe a clear before-and-after change. Fitness, cognition, digestion, sleep, and resilience may all shift after infection.
In this group, testing can be part of a wider long COVID assessment. It may sit alongside inflammatory markers, clotting markers, autonomic symptoms, gut health, mitochondrial support, nutrient status, and pacing strategies.
People with symptoms after vaccination
Some people report symptom onset after vaccination. This is a sensitive area and needs non-judgemental assessment.
Testing may help identify whether spike material is detectable, but it unfortunately it cannot be used to prove that vaccination caused every symptom. A balanced approach should consider previous infection, immune history, medications, autoimmune background, and other exposures.
People with complex chronic illness made worse after COVID infection of vaccination exposure
A third group already has chronic symptoms, such as fatigue, pain, gut issues, environmental sensitivities, or immune dysregulation. After COVID infection or vaccination, they worsen and struggle to return to their previous baseline.
For these people, MMD lab testing may be one layer in a much larger picture. If the body was already under strain, an additional immune challenge may reveal weak points in detoxification, mitochondrial function, gut resilience, coagulation balance, or nervous system regulation.
What testing cannot tell us
It is easy to over-interpret a lab result which can lead to unnecessary anxiety or aggressive treatment.
S1 and N1 protein testing cannot reliably tell us:
All the sites where related material is located in the body
Whether it is definitely causing symptoms
How long it has been present
Which treatment will work
Whether a person is safe to ignore other health issues
A result is a clue, not a complete diagnosis. The most useful approach is to ask, “Does this result fit the clinical picture, and does it change what we do next?”
Interventions being used to support clearance
There is currently no single approved “spike clearance protocol” that works for everyone. Research is still developing, and responses vary. In practice, interventions tend to focus on reducing inflammatory burden, supporting elimination pathways, improving resilience, and avoiding symptom flares.
Any intervention should be personalised, especially for people who are sensitive, medicated, pregnant, breastfeeding, immunocompromised, or living with complex conditions.
Supporting the gut and bile pathways
The gut is a major route for immune signalling and waste elimination. If constipation, poor bile flow, dysbiosis, or gut inflammation are present, people often tolerate detoxification poorly.
Clinical support may include:
Improving bowel regularity
Supporting nutrient intake, if tolerated
Addressing constipation before adding binders
Considering bile flow support where appropriate
Reviewing food sensitivities
Supporting the gut lining and microbiome health
Binders are sometimes used by practitioners to reduce reabsorption of inflammatory compounds in the gut. Examples may include charcoal, clay, modified citrus pectin, chlorella, or specific fibre compounds. They can also bind medications and nutrients, so timing and suitability matter.
Reducing inflammatory load
Other interventions include nutritional and botanical support to calm inflammatory signalling. Common areas of focus include omega-3 status, antioxidant intake, polyphenols, vitamin D, magnesium, and correction of deficiencies.
Compounds such as quercetin, curcumin, resveratrol and luteolin, are often discussed in post-viral care. The evidence varies by compound and condition, and they are not suitable for everyone.
The principle is simple: lower the total inflammatory load so the body has more capacity to repair.
Supporting mitochondrial function with a terrain based approach
Many people with long COVID symptoms describe a clear energy problem. They may feel worse after exertion, experience delayed crashes, or struggle with mental stamina.
Support often includes:
Careful pacing rather than forced exercise
Adequate protein and mineral intake
Appropriate hydration strategies
Sleep and blood sugar stabilisation
Carefully curated flare plans
Quantum biology tools which support magnetic flux, circadian timing of cells and appropraite daytime and night time signals
For people with post-exertional symptom worsening, pushing through can backfire. The first goal is often stability, not fitness.
Considering circulation and clotting markers
Some post-COVID research has explored endothelial dysfunction, platelet activation, and micro-clotting. This is a complex area and should be managed medically, not casually self-treated.
In appropriate cases, clinicians may review markers related to clotting, inflammation, vascular function, and cardiovascular risk. Some people are already taking anticoagulant or antiplatelet medication, which makes supervision essential.
Natural agents often discussed online can still carry bleeding risk, especially when combined with medication. More is not always better.
Calming mast cell and histamine reactions
Some people develop new reactivity after COVID exposure. They may react to foods, alcohol, heat, stress, supplements, or exertion. In these cases, aggressive detoxification can make symptoms worse.
Support may involve:
Identifying high-histamine triggers
Stabilising meals and blood sugar
Reducing alcohol and fermented foods if reactive
Using antihistamines or mast cell support where appropriate
Introducing supplements slowly
Avoiding large treatment stacks
Stabilisation often needs to come before clearance.
Why the order of treatment matters
One of the biggest mistakes I see is trying to clear spike-related material before the body is ready. If someone is constipated, inflamed, sleep-deprived, nutritionally depleted, highly reactive, and has uncontrolled PoTS, MCAS or hEDS, adding multiple binders, fasting, sauna, intense exercise, and strong antimicrobials may trigger a crash.
A safer sequence often looks like this:
Stabilise first
Reduce triggers
Support elimination
Reassess
Sleep, hydration, bowel regularity, blood sugar, pacing, and symptom tracking
Food reactions, alcohol, overtraining, mould exposure, infections, and unmanaged stress physiology
Gut, bile, lymphatic movement, sweating if tolerated, and careful binder use
Symptoms, function, inflammatory markers, and repeat testing where useful
Testing can help shape the plan, but the body still needs the basics in place.
How to use test results without becoming fixated on them
Lab markers can be empowering. They can also become stressful. I encourage people to track function as well as numbers.
Useful real-world markers include:
Can you walk further without a flare?
Is your sleep more restorative?
Are crashes less frequent or less severe?
Is brain fog improving?
Are you tolerating more foods?
Is your heart rate more stable?
Can you work, parent, exercise, or socialise with fewer setbacks?
A falling marker is encouraging, but lived improvement matters most.
Current projects
The most promising part of this field is that clinicians, laboratories, and researchers are starting to ask better questions. Current projects around spike protein testing appear to focus on improving detection, understanding persistence, learning which symptoms correlate with findings, and assessing how markers change over time.
This matters because people with persistent symptoms need more than reassurance. They need careful investigation, better tools, and treatment approaches that are tested, refined, and made safer.
A YouTube update has highlighted some of the projects currently being worked on. If you are following this area, it is worth watching the project update directly so you can hear the aims, limitations, and next steps in context:
The main takeaway
MMD Labs testing may provide useful information for people with persistent symptoms after COVID-19 infection, vaccination, or both. Its strength is not that it gives a single simple answer. Its strength is that it can add another layer of evidence when the clinical picture is complex and can provide data that interventions are beneficial.
The best use of testing is careful and measured:
Interpret results alongside symptoms and history
Look for wider immune, inflammatory, gut, vascular, and mitochondrial patterns
Start with stabilisation before aggressive clearance
Track function, as well as lab numbers
Reassess over time rather than reacting to one result
This advanced testing is an evolving field. Used well, it can help guide better questions, safer interventions, and more personalised care.
If you would like us to support you on your health journey the please feel free to book in for your free 15 minute call with the clinic.
Comments